Novocure limited (NVCR)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Sep'14
Net revenues

379,837

351,318

321,758

294,452

269,253

248,069

232,056

217,409

194,271

177,026

153,607

125,172

104,715

82,888

65,029

52,308

40,932

33,087

25,078

0

0

0

Cost of revenues

93,288

88,606

86,848

82,897

81,624

80,048

72,661

68,865

62,184

55,610

50,942

46,907

43,552

39,870

35,201

29,742

24,695

20,610

16,892

0

0

0

Impairment of field equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

Gross profit

286,549

262,712

234,910

211,555

187,629

168,021

159,396

148,545

132,088

121,417

102,665

78,265

54,751

36,606

23,416

16,154

16,237

12,477

8,186

0

0

0

Operating costs and expenses:
Research, development and clinical trials

87,232

79,003

70,296

64,604

56,512

50,574

45,588

41,787

39,796

38,103

36,526

37,486

39,433

41,467

43,841

43,819

45,266

43,748

42,179

0

0

0

Sales and marketing

103,176

96,675

91,079

86,373

81,861

77,663

72,480

69,743

66,907

63,528

63,181

62,659

60,897

59,449

58,495

51,546

45,814

38,861

29,521

0

0

0

General and administrative

94,318

87,948

83,266

79,410

76,369

73,456

70,842

67,202

64,017

59,114

55,657

53,165

51,173

51,007

49,126

44,808

39,145

33,864

27,781

0

0

0

Total operating costs and expenses

284,726

263,626

244,641

230,387

214,742

201,693

188,910

178,732

170,720

160,745

155,364

153,310

151,503

151,923

151,462

140,173

130,225

116,473

99,481

0

0

0

Operating income (loss)

1,823

-914

-9,731

-18,832

-27,113

-33,672

-29,514

-30,187

-38,632

-39,328

-52,699

-75,045

-96,752

-115,317

-128,046

-124,019

-113,988

-103,996

-91,295

0

0

0

Financial expenses (income), net

7,971

7,910

8,325

8,167

9,788

12,270

12,494

12,253

11,576

9,169

9,639

9,672

8,044

6,147

4,168

2,788

3,109

3,151

2,329

0

0

0

Income (loss) before income tax

-6,148

-8,824

-18,056

-26,999

-36,901

-45,942

-42,008

-42,440

-50,208

-48,497

-62,338

-84,717

-104,796

-121,464

-132,214

-126,807

-117,097

-107,147

-93,624

0

0

0

Income tax

-15,020

-1,594

9,065

13,746

18,084

17,617

16,865

16,237

14,133

13,165

10,547

10,298

9,657

10,381

10,391

8,193

6,648

4,434

3,349

0

0

0

Net income (loss)

8,872

-7,230

-27,121

-40,745

-54,985

-63,559

-58,873

-58,677

-64,341

-61,662

-72,885

-95,015

-114,453

-131,845

-142,605

-135,000

-123,745

-111,581

-96,973

0

0

0

Basic net income (loss) per ordinary share (in usd per share)

0.04

-

0.02

-

-0.13

-

-0.13

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average number of ordinary shares used in computing basic net income (loss) per share (in shares)

99,877

-

98,485

-

94,811

-

92,911

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted net income (loss) per ordinary share (in usd per share)

0.04

-

0.02

-

-0.13

-

-0.13

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average number of ordinary shares used in computing diluted net income (loss) per share (in shares)

108,100

-

107,604

-

94,811

-

92,911

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic and diluted net income (loss) per ordinary share (in usd per share)

-

-

-

-0.01

-

-

-

-0.17

-0.23

-0.12

-0.13

-0.24

-0.21

-0.25

-0.39

-0.48

-0.42

2.55

-2.09

-2.36

-1.77

-1.45

Weighted average number of ordinary shares used in computing basic and diluted net income (loss) per share (in shares)

-

-

-

96,356

-

-

-

91,331

89,985

89,389

89,125

88,218

87,452

86,787

85,774

85,274

84,397

83,607

12,431

12,427

13,140

12,594